Centiva Capital’s NuVasive, Inc. NUVA Stock Holding History

Centiva Capital’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,175	Closed	-$548K	–	2245
2023 Q2	$548K	Buy	13,175 +2,979	+29%	+$122K	0.01%	787
2023 Q1	$421K	Buy	+10,196	New	+$436K	0.01%	908
2022 Q4	–	Sell	-1,124	Closed	-$49K	–	1744
2022 Q3	$49K	Buy	+1,124	New	+$54.5K	﹤0.01%	1332
2022 Q1	–	Sell	-13,971	Closed	-$733K	–	1900
2021 Q4	$733K	Buy	+13,971	New	+$759K	0.02%	696
2021 Q3	–	Sell	-9,316	Closed	-$631K	–	1707
2021 Q2	$631K	Buy	9,316 +364	+4%	+$24.9K	0.01%	737
2021 Q1	$587K	Buy	+8,952	New	+$537K	0.02%	503
2019 Q4	–	Sell	-6,594	Closed	-$418K	–	956
2019 Q3	$418K	Buy	+6,594	New	+$412K	0.03%	367

Other funds holding NUVA

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Centiva Capital's NUVA Position: Q3 2023 in Review

Centiva Capital sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 13,175 shares — an estimated $548K sold.

Centiva Capital first reported a position in NUVA in Q3 2019 and held it in 7 quarters. The position peaked at $733K in Q4 2021. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

Centiva Capital reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
Centiva Capital sold 13,175 NuVasive, Inc. shares in Q3 2023, an estimated $548K.
Centiva Capital first reported a position in NuVasive, Inc. in Q3 2019 and held it in 7 quarters.
Centiva Capital's NuVasive, Inc. position peaked at $733K in Q4 2021.
2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Centiva Capital's 13F filing for Q3 2023, filed 14 Nov 2023.